Zum Hauptinhalt springen

Hepatitiden

13. September 2023 | Hepatitiden

A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study

A ‘one-stop-shop’ point-of-care hepatitis C RNA testing intervention to enhance treatment uptake in a reception prison: The PIVOT study Sheehan, Yumi et al. Journal of Hepatology, Volume 79, Issue 3, 635 - 644 https://www.journal-of-hepatology…

13. September 2023 | Hepatitiden

RKI. Epidemiologisches Bulletin: Welt-Hepatitis-Tag: Hepatitis B und Hepatitis C in Deutschland 2022 - Anstieg der übermittelten Hepatitis-B- und Hepatitis-C-Fälle in Deutschland im Jahr 2022.

RKI. Epidemiologisches Bulletin: Welt-Hepatitis-Tag: Hepatitis B und Hepatitis C in Deutschland 2022 - Anstieg der übermittelten Hepatitis-B- und Hepatitis-C-Fälle in Deutschland im Jahr 2022. Im Jahr 2022 konnte für Deutschland ein stetiger bu…

13. September 2023 | Hepatitiden

Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review.

Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review. Hsu CC, Gopalakrishna H, Mironova M, Lee MH, Chen CJ…

13. September 2023 | Hepatitiden

Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis.

Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian Analysis. Nava FA, Mangia A, Riglietta M, Somaini L, Foschi FG…

13. September 2023 | Hepatitiden

Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment.

Engaging people who use drugs in clinical research: integrating facilitated telemedicine for HCV into substance use treatment. Talal AH, George SJ, Talal LA, Dharia A, Ventuneac A, Baciewicz G, Perumalswami PV, Dickerson SS.&nbs…

13. September 2023 | Hepatitiden

Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C.

Training the healthcare workforce: the global experience with telementorship for hepatitis B and hepatitis C. Corcorran MA, Thornton K, Struminger B, Easterbrook P, Scott JD. BMC Health Serv Res. 2023 Aug 2;23(1):824. doi: 10.1186/s12913…

13. September 2023 | Hepatitiden

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study.

Mortality rates among patients successfully treated for hepatitis C in the era of interferon-free antivirals: population based cohort study. Hamill V, Wong S, Benselin J, Krajden M, Hayes PC, Mutimer D, Yu A, Dillon JF, Gelson W, Velásquez Gar…

Weitere Beiträge ansehen

Weitere
akutelle Informationen
zu den Themengebieten